News & Analysis on Clinical Trial Services & Contract Research And Development
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Genzyme adding more manufacturing experience and resignations at Uluru and Par.
US CRO Quintiles expands PI3K assay offering, predicting increased drug industry demand for expertise in key survival pathway in era of personalised cancer treatments.
Increasing customer demand for integrated and flexible systems were the drivers behind developing new vertical flat pouch equipment for packing a range of free-flowing goods including granulates and powders, said Bosch Packaging Technology.
KV Pharmaceuticals has decided to cut its losses and sell its subsidiary Particle Dynamics in a deal worth $24.6m (€20.6m). The deal adds some much needed stability as the business attempts to shore up its finances during a difficult period.
LGR Emballages, has announced a substantial investment in three Speedmaster XL 105 presses that the French packaging group hope will improve its current short-run productivity for pharmaceutical packaging.
CRO PFC Pharma Focus is using a HMO database to provide feasibility information before a clinical trial starts, reducing costs, risks and developmental timelines.
US-based Albemarle is building a kilo lab in Louvain la Neuve, Belgium to meet demand from European clients for services beyond bench scale.
Chiltern’s early phase unit in Dundee, Scotland has achieved supplementary accreditation from the Medicines and Healthcare products Regulatory Agency (MHRA).
The Consortium for the Advancement of Patient Safety (CAPS) says research shows that USP plans to restrict printing on pharmaceutical vial ferrules and caps are “ambiguous and vague.”